Exchange: OTC·Updated 07:30 PM EST

About ELOX

About

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10

Frequently Asked Questions

Advertisement|Remove ads.